Search Within

Peter Maslak

  1. "Biostatistics Service"
Formats
  1. Journal Article (16)
  2. Meeting Abstract (11)
  3. Conference Paper (1)
Groups
  1. Adult Leukemia (28)
  2. Biostatistics Service (28)
  3. Center for Hematologic Malignancies (28)
  4. Department of Medicine (28)
  5. Epidemiology and Biostatistics (28)
  6. Hematologic Malignancies, Division of (28)

More Groups

People
  1. Sean Devlin (11)
  2. David Scheinberg (10)
  3. Renier Brentjens (9)
  4. Joseph Jurcic (8)
  5. Katherine Panageas (8)
  6. Sergio Giralt (8)

More People

Years
  1. 2022 (1)
  2. 2021 (3)
  3. 2020 (1)
  4. 2019 (1)
  5. 2018 (3)
  6. 2014 (2)

More Years

Publications
  1. Blood (9)
  2. Journal of Clinical Oncology (4)
  3. Biology of Blood and Marrow Transplantation (2)
  4. Leukemia (2)
  5. Bone Marrow Transplantation (1)
  6. Cancer (1)

More Publications

Publishers
  1. American Society of Hematology (9)
  2. American Society of Clinical Oncology (4)
  3. Elsevier Inc. (4)
  4. Nature Publishing Group (3)
  5. American Association for Cancer Research (1)
  6. American Association for the Advancement of Science (1)

More Publishers

Results (28)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Efficacy and toxicity management of 19-28z CAR T cell therapy in B cell acute lymphoblastic leukemia
    Journal Article

    Davila, M. L.; Riviere, I.; Wang, X.; Bartido, S.; Park, J.; Curran, K.; Chung, S. S.; Stefanski, J.; Borquez-Ojeda, O.; Olszewska, M.; more...
    Science Translational Medicine (2014)

    Fulltext@MSK | Save
  • Multiparameter flow cytometry for detection of minimal residual disease in multiple myeloma after T-cell depleted allogeneic stem cell transplant
    Meeting Abstract

    Kosuri, S.; Smith, K. M.; Kuk, D.; Devlin, S. M.; Maslak, P. G.; Giralt, S.; Koehne, G.
    Blood (2013)

    Fulltext@MSK | Save
  • Final product composition after ex-vivo T-cell reduction: Miltenyi clinimacs versus baxter isolex 300i in a large cohort of allogeneic transplant patients
    Meeting Abstract

    Tonon, J.; Koehne, G.; Collins, N. H.; Malloy, M.; Chen, X.; Bleau, S.; Pessin, M.; Smith, K.; Maslak, P.; Devlin, S.; more...
    Cytotherapy (2013)

    Fulltext@MSK | Save
  • Treatment of adults with acute lymphoblastic leukemia: Do the specifics of the regimen matter?: Results from a prospective randomized trial
    Journal Article

    Lamanna, N.; Heffner, L. T.; Kalaycio, M.; Schiller, G.; Coutre, S.; Moore, J.; Seiter, K.; Maslak, P.; Panageas, K.; Golde, D.; more...
    Cancer (2013)

    Fulltext@MSK | Save
  • Acute myeloid leukemia with translocation t(8;16) presents with features which mimic acute promyelocytic leukemia and is associated with poor prognosis
    Journal Article

    Diab, A.; Zickl, L.; Abdel-Wahab, O.; Jhanwar, S.; Gulam, M. A.; Panageas, K. S.; Patel, J. P.; Jurcic, J.; Maslak, P.; Paietta, E.; more...
    Leukemia Research (2013)

    Fulltext@MSK | Save
  • Aerobic glycolysis predicts outcome in early chronic lymphocytic leukemia
    Meeting Abstract

    Gardner, J. R.; Devlin, S.; Knapp, K.; Bauli, F.; Lamanna, N.; Frattini, M. G.; Brentjens, R. J.; Maslak, P. G.; Jurcic, J. G.; Weiss, M.; more...
    Blood (2012)

    Fulltext@MSK | Save
  • Randomized, double-blinded, phase II trial of a WT1 peptide vaccine as adjuvant therapy in patients with malignant pleural mesothelioma (MPM)
    Meeting Abstract

    Krug, L. M.; Tsao, A. S.; Kass, S.; Rusch, V. W.; Travis, W. D.; Panageas, K.; Adusumili, P. S.; Kris, M. G.; Maslak, P. G.; Scheinberg, D. A.
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Safety and persistence of adoptively transferred autologous CD19-targeted T cells in patients with relapsed or chemotherapy refractory B-cell leukemias
    Journal Article

    Brentjens, R. J.; Riviere, I.; Park, J. H.; Davila, M. L.; Wang, X.; Stefanski, J.; Taylor, C.; Yeh, R.; Bartido, S.; Borquez-Ojeda, O.; more...
    Blood (2011)

    Fulltext@MSK | Save
  • Sequential therapy with fludarabine, high-dose cyclophosphamide, and rituximab in previously untreated patients with chronic lymphocytic leukemia produces high-quality responses: Molecular remissions predict for durable complete responses
    Journal Article

    Lamanna, N.; Jurcic, J. G.; Noy, A.; Maslak, P.; Gencarelli, A. N.; Panageas, K. S.; Heaney, M. L.; Brentjens, R. J.; Golde, D. W.; Scheinberg, D. A.; more...
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • Tolerability, pharmacodynamics, and pharmacokinetics studies of depsipeptide (Romidepsin) in patients with acute myelogenous leukemia or advanced myelodysplastic syndromes
    Journal Article

    Klimek, V. M.; Fircanis, S.; Maslak, P.; Guernah, I.; Baum, M.; Wu, N.; Panageas, K.; Wright, J. J.; Pandolfi, P. P.; Nimer, S. D.
    Clinical Cancer Research (2008)

    Fulltext@MSK | Save